Dr Dimitri Yellachich
Director of LLM and NLP Research
MBBS, BMedSci, FRANZCO

Dr. Dimitri Yellachich is a distinguished ophthalmologist and biomedical technology innovator, currently serving as the Director of Large Language Model (LLM) and Natural Language Processing (NLP) Research at i-scribe. He holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) and a Bachelor of Medical Science (BMedSci) from the University of Western Australia, and is a Fellow of the Royal Australian and New Zealand College of Ophthalmologists (FRANZCO).

Professional Background

Dr. Yellachich completed his general ophthalmology training in Perth, followed by subspecialty training in medical and surgical retina at the Western Eye Hospital in London and Stanford University in California.

With a special interest in biomedical technology, Dr. Yellachich was instrumental in developing the PAtterned SCAnning Laser (PASCAL), a now-standard tool in retinal laser treatments for conditions like diabetic retinopathy and retinal vein occlusions.

Role at i-scribe

At i-scribe, Dr. Yellachich leads research initiatives in LLM and NLP, focusing on integrating advanced AI technologies into healthcare documentation. His extensive experience in ophthalmology and biomedical innovation positions him uniquely to bridge clinical expertise with technological advancements, enhancing clinician workflows and patient care.

Philosophy on Work

Dr. Yellachich is committed to leveraging technology to improve healthcare delivery. His work at i-scribe reflects a dedication to developing AI solutions that streamline clinical documentation, allowing healthcare professionals to focus more on patient care.

Hobbies and Interests

Outside of his professional endeavors, Dr. Yellachich is passionate about continuous learning and staying abreast of the latest developments in ophthalmic imaging and surgical techniques.